Statistics

Total Visits

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients59

Select a period of time:

Number of views in the range

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients28

Views

Views
April 20253
May 20252
June 202510
July 202511
August 20250
September 20252
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong10
Brazil6
United States4
Argentina1
Canada1
Spain1
Mexico1
Slovenia1
Tunisia1
Turkey1
 

Top cities views

Views
Hong Kong10
Dallas2
Ameca1
Atlanta1
Aydin1
Belo Horizonte1
Council Bluffs1
Goiânia1
Paracatu1
Tangará da Serra1